IDEXX Laboratories Inc
IDXX535.540USD
+1.230+0.23%
종가 08/01, 16:00（ET）시세는 15분 지연됩니다
43.24B시가총액
48.31P/E TTM
자세한 내용은 IDEXX Laboratories Inc 회사
IDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services primarily for the companion animal veterinary, livestock and poultry, dairy and water testing industries. The Company also provides human medical point-of-care and laboratory diagnostics. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment offers diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment provides testing solutions for accurate detection and quantification of various microbiological parameters in water. The LPD segment provides diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, and to improve the quality and safety of milk.
회사 정보
종목 코드 IDXX
회사 이름IDEXX Laboratories Inc
상장일Jun 21, 1991
설립일1983
CEOMr. Andrew Emerson
직원 수11000
유형Ordinary Share
회계 연도 종료Jun 21
주소One Idexx Drive
도시WESTBROOK
증권 거래소NASDAQ Global Select Consolidated
국가United States of America
우편 번호04092-2041
전화12075560300
웹사이트https://www.idexx.com/
종목 코드 IDXX
상장일Jun 21, 1991
설립일1983
회사 임원
이름
이름/직위
직위
주식 보유
변동
Mr. Michael Erickson, Ph.D.
Mr. Michael Erickson, Ph.D.
Executive Vice President and General Manager, Point of Care Diagnostics and Telemedicine
Executive Vice President and General Manager, Point of Care Diagnostics and Telemedicine
12.58K
+18.05%
Dr. Sophie V. Vandebroek, Ph.D.
Dr. Sophie V. Vandebroek, Ph.D.
Independent Director
Independent Director
8.69K
+3.11%
Mr. Lawrence D. (Larry) Kingsley
Mr. Lawrence D. (Larry) Kingsley
Independent Chairman of the Board
Independent Chairman of the Board
8.23K
+4.39%
Mr. Michael J. Lane
Mr. Michael J. Lane
Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology
Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology
7.70K
+0.61%
Ms. Sharon E. Underberg
Ms. Sharon E. Underberg
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
5.93K
+8.90%
Mr. Daniel M. (Dan) Junius
Mr. Daniel M. (Dan) Junius
Independent Director
Independent Director
3.00K
+9.56%
Mr. Andrew Emerson
Mr. Andrew Emerson
Executive Vice President, Chief Executive Officer, Treasurer
Executive Vice President, Chief Executive Officer, Treasurer
2.40K
--
Mr. Michael Schreck
Mr. Michael Schreck
Executive Vice President and General Manager, Veterinary Software and Services, Corporate Accounts and Customer Experience
Executive Vice President and General Manager, Veterinary Software and Services, Corporate Accounts and Customer Experience
1.92K
+112.86%
Mr. Bruce L. Claflin
Mr. Bruce L. Claflin
Independent Director
Independent Director
1.72K
--
Dr. Stuart M. Essig, Ph.D.
Dr. Stuart M. Essig, Ph.D.
Independent Director
Independent Director
1.09K
+31.76%
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Michael Erickson, Ph.D.
Mr. Michael Erickson, Ph.D.
Executive Vice President and General Manager, Point of Care Diagnostics and Telemedicine
Executive Vice President and General Manager, Point of Care Diagnostics and Telemedicine
12.58K
+18.05%
Dr. Sophie V. Vandebroek, Ph.D.
Dr. Sophie V. Vandebroek, Ph.D.
Independent Director
Independent Director
8.69K
+3.11%
Mr. Lawrence D. (Larry) Kingsley
Mr. Lawrence D. (Larry) Kingsley
Independent Chairman of the Board
Independent Chairman of the Board
8.23K
+4.39%
Mr. Michael J. Lane
Mr. Michael J. Lane
Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology
Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology
7.70K
+0.61%
Ms. Sharon E. Underberg
Ms. Sharon E. Underberg
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
5.93K
+8.90%
Mr. Daniel M. (Dan) Junius
Mr. Daniel M. (Dan) Junius
Independent Director
Independent Director
3.00K
+9.56%
수익 분석
통화: USD마지막 업데이트: Sun, Jul 6
통화: USD마지막 업데이트: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
사업별USD
이름
수익
비율
CAG Diagnostics recurring revenue
806.27M
80.75%
IDEXX VetLab consumables
344.78M
34.53%
Reference laboratory diagnostic and consulting services
344.41M
34.49%
Rapid assay products
84.03M
8.42%
Veterinary software, services and diagnostic imaging systems
81.58M
8.17%
Other
-662.63M
-66.37%
지역별USD
이름
수익
비율
United States
654.86M
65.59%
Europe & Middle East & Africa (EMEA) (Region)
204.55M
20.49%
Asia Pacific
81.73M
8.19%
Canada
37.30M
3.74%
Latin America
19.99M
2.00%
사업별
지역별
사업별USD
이름
수익
비율
CAG Diagnostics recurring revenue
806.27M
80.75%
IDEXX VetLab consumables
344.78M
34.53%
Reference laboratory diagnostic and consulting services
344.41M
34.49%
Rapid assay products
84.03M
8.42%
Veterinary software, services and diagnostic imaging systems
81.58M
8.17%
Other
-662.63M
-66.37%
주식 보유 통계
마지막 업데이트: Thu, Jul 24
마지막 업데이트: Thu, Jul 24
주주
주주 유형
주주
주주
비율
The Vanguard Group, Inc.
12.21%
BlackRock Institutional Trust Company, N.A.
6.76%
State Street Global Advisors (US)
4.54%
Fundsmith LLP
3.29%
Geode Capital Management, L.L.C.
3.00%
Other
70.20%
주주
주주
비율
The Vanguard Group, Inc.
12.21%
BlackRock Institutional Trust Company, N.A.
6.76%
State Street Global Advisors (US)
4.54%
Fundsmith LLP
3.29%
Geode Capital Management, L.L.C.
3.00%
Other
70.20%
주주 유형
주주
비율
Investment Advisor
56.49%
Investment Advisor/Hedge Fund
29.33%
Research Firm
3.99%
Pension Fund
2.28%
Bank and Trust
2.04%
Hedge Fund
1.86%
Sovereign Wealth Fund
1.32%
Individual Investor
0.68%
Family Office
0.48%
Other
1.55%
기관 주식 보유
마지막 업데이트: Tue, Jul 1
마지막 업데이트: Tue, Jul 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q2
2259
79.04M
98.28%
-694.13K
2025Q1
2279
79.02M
98.21%
-512.23K
2024Q4
2242
76.14M
93.59%
-5.30M
2024Q3
2152
77.90M
94.66%
-4.67M
2024Q2
2140
80.09M
96.98%
-924.14K
2024Q1
2154
77.56M
93.40%
-2.57M
2023Q4
2187
77.94M
93.84%
-2.83M
2023Q3
2153
79.23M
95.34%
-677.16K
2023Q2
2157
77.53M
93.40%
-1.56M
2023Q1
2158
77.14M
92.96%
-2.07M
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
The Vanguard Group, Inc.
9.82M
12.21%
+146.37K
+1.51%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
5.44M
6.76%
+113.70K
+2.14%
Mar 31, 2025
State Street Global Advisors (US)
3.65M
4.54%
+12.32K
+0.34%
Mar 31, 2025
Fundsmith LLP
2.65M
3.29%
-14.52K
-0.55%
Mar 31, 2025
Geode Capital Management, L.L.C.
2.41M
3%
+112.62K
+4.90%
Mar 31, 2025
Baron Capital Management, Inc.
2.06M
2.56%
+54.26K
+2.71%
Mar 31, 2025
T. Rowe Price Associates, Inc.
1.87M
2.33%
+824.75K
+78.91%
Mar 31, 2025
Invesco Capital Management (QQQ Trust)
1.66M
2.07%
-25.31K
-1.50%
Jun 30, 2025
BlackRock Asset Management Ireland Limited
1.14M
1.42%
+15.87K
+1.41%
Mar 31, 2025
Principal Global Investors (Equity)
1.13M
1.4%
+414.80K
+58.32%
Mar 31, 2025
더 보기
관련 ETF
마지막 업데이트: 3 hours ago
마지막 업데이트: 3 hours ago
이름
비율
ProShares Pet Care ETF
10.23%
First Trust Water ETF
4.73%
iShares U.S. Medical Devices ETF
4.5%
Nuveen ESG Mid-Cap Growth ETF
3.28%
First Trust S&P 500 Economic Moat Index ETF
2.32%
Adaptive Core ETF
2.29%
Invesco Raymond James SB-1 Equity ETF
2.1%
Putnam Sustainable Future ETF
1.94%
SPDR S&P Health Care Equipment ETF
1.87%
First Trust NASDAQ-100 Ex-Technology Sector Index Fund
1.8%
더 보기
ProShares Pet Care ETF
비율10.23%
First Trust Water ETF
비율4.73%
iShares U.S. Medical Devices ETF
비율4.5%
Nuveen ESG Mid-Cap Growth ETF
비율3.28%
First Trust S&P 500 Economic Moat Index ETF
비율2.32%
Adaptive Core ETF
비율2.29%
Invesco Raymond James SB-1 Equity ETF
비율2.1%
Putnam Sustainable Future ETF
비율1.94%
SPDR S&P Health Care Equipment ETF
비율1.87%
First Trust NASDAQ-100 Ex-Technology Sector Index Fund
비율1.8%
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
유형
비율
데이터 없음
날짜
유형
비율
데이터 없음
